Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lercadip
2. Lercanidipine
3. Lerdip
4. Methyl-1,1-dimethyl-2-(n-(3,3-diphenylpropyl)-n-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
5. Rec 15-2375
6. Rec-15-2375
7. Zanidip
1. 132866-11-6
2. Lercanidipine Hcl
3. Cardiovasc
4. Corifeo
5. Carmen
6. Lercadip
7. Lerzam
8. Lercan
9. Rec-15/2375
10. Lercanidipine (hydrochloride)
11. Lercanidipine Hydrochloride Hemihydrate
12. 3-(1-((3,3-diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
13. Lercanidipine Hydrochloride [usan]
14. Oa8tfx68pe
15. 100427-27-8
16. 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
17. Lercapin
18. Lercaton
19. Lerkamen
20. Renovia
21. Vasodip
22. Zanicor
23. Zandip
24. Dsstox_cid_26665
25. Dsstox_rid_81807
26. Dsstox_gsid_46665
27. Zanidip
28. (r)-lercanidipine (hydrochloride)
29. (s)-lercanidipine (hydrochloride)
30. Lerdip
31. 2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl (4rs)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Monohydrochloride
32. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl Ester, Monohydrochloride
33. 3-(1-((3,3-diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride(1:x)
34. Cas-132866-11-6
35. Lercanidipinehcl
36. Zanidip (hydrochloride)
37. Ncgc00167492-01
38. Unii-oa8tfx68pe
39. Masnidipine (hydrochloride)
40. R 75
41. Zanedip
42. Cardiovasc (tn)
43. Lcp-lerc
44. Zanidip Hydrochloride
45. Masnidipine Hydrochloride
46. Schembl217099
47. Chembl2106419
48. Dtxsid3046665
49. Chebi:31771
50. Hy-b0612a
51. Lercanidipine-[d3] Hydrochloride
52. Tjn-324
53. Lercanidipine Hydrochloride (1:x)
54. Lercanidipine Hydrochloride- Bio-x
55. Bcp11375
56. Tox21_112493
57. Tox21_500144
58. Mfcd07773089
59. S4597
60. Akos015846519
61. Tox21_112493_1
62. Ac-1420
63. Ccg-221448
64. Ccg-270327
65. Lp00144
66. Lercanidipine Hydrochloride (jan/usan)
67. Lercanidipine Hydrochloride [mi]
68. Lercanidipine Hydrochloride [jan]
69. Ncgc00167492-03
70. Ncgc00260829-01
71. As-13358
72. Bl164618
73. Lercanidipine Hydrochloride [mart.]
74. Db-042142
75. Lercanidipine Hydrochloride [who-dd]
76. Ft-0627794
77. Ft-0631144
78. Ft-0670749
79. Ft-0670750
80. L0282
81. Lercanidipine Hydrochloride, >=98% (hplc)
82. D01849
83. 866l116
84. A806509
85. J-006235
86. J-006236
87. J-521641
88. Q27285537
89. 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-diphenylpropyl)
90. 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic Acid O5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] Ester O3-methyl Ester Hydrochloride
91. 3,3-diphenylpropyl-[2-[5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carbonyl]oxy-2-methylpropyl]-methylazanium;chloride
92. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl Methyl Ester, Monohydrochloride
93. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-methyl Ester, Hydrochloride (1:1)
94. O5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methyl-propan-2-yl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
| Molecular Weight | 648.2 g/mol |
|---|---|
| Molecular Formula | C36H42ClN3O6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 13 |
| Exact Mass | 647.2762138 g/mol |
| Monoisotopic Mass | 647.2762138 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 1090 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Lercanidipine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lercanidipine HCl, including repackagers and relabelers. The FDA regulates Lercanidipine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lercanidipine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lercanidipine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lercanidipine HCl supplier is an individual or a company that provides Lercanidipine HCl active pharmaceutical ingredient (API) or Lercanidipine HCl finished formulations upon request. The Lercanidipine HCl suppliers may include Lercanidipine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Lercanidipine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lercanidipine HCl written confirmation (Lercanidipine HCl WC) is an official document issued by a regulatory agency to a Lercanidipine HCl manufacturer, verifying that the manufacturing facility of a Lercanidipine HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lercanidipine HCl APIs or Lercanidipine HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Lercanidipine HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Lercanidipine HCl suppliers with Written Confirmation (WC) on PharmaCompass.
Lercanidipine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lercanidipine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lercanidipine HCl GMP manufacturer or Lercanidipine HCl GMP API supplier for your needs.
A Lercanidipine HCl CoA (Certificate of Analysis) is a formal document that attests to Lercanidipine HCl's compliance with Lercanidipine HCl specifications and serves as a tool for batch-level quality control.
Lercanidipine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Lercanidipine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lercanidipine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Lercanidipine HCl EP), Lercanidipine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lercanidipine HCl USP).
LOOKING FOR A SUPPLIER?
